(Q38869957)

7 September 2017

Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas (English)

1 reference

7 September 2017

S A Choi

1

1 reference

7 September 2017

Y E Lee

2

1 reference

7 September 2017

P A Kwak

3

1 reference

7 September 2017

J Y Lee

4

1 reference

7 September 2017

S S Kim

5

1 reference

7 September 2017

S J Lee

6

1 reference

7 September 2017

J H Phi

7

1 reference

7 September 2017

K-C Wang

8

1 reference

7 September 2017

J Song

9

1 reference

7 September 2017

S H Song

10

1 reference

7 September 2017

K M Joo

11

1 reference

7 September 2017

S-K Kim

12

1 reference

7 September 2017

29 May 2015

1 reference

7 September 2017

1 reference

7 September 2017

22

1 reference

7 September 2017

6

1 reference

7 September 2017

302-311

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2015.25

7 September 2017

0 references

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Multipotential differentiation of adipose tissue-derived stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Stem cell therapy for neurologic disorders: therapeutic potential of adipose-derived stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Human adipose-derived stem cells: potential clinical applications in surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Stem cells are resistant to TRAIL receptor-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Gene therapy for malignant glioma: current clinical status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Experience with irinotecan for the treatment of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Targeting of melanoma brain metastases using engineered neural stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

TRAIL gene therapy: from preclinical development to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

APO2 ligand: a novel lethal weapon against malignant glioma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

TRAIL receptor signalling and modulation: Are we on the right TRAIL?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Prodrug cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Human neural stem cells genetically modified for brain repair in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Lentivirus-mediated CD/TK fusion gene transfection neural stem cell therapy for C6 glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.25

Functional analysis of TRAIL receptors using monoclonal antibodies

21 January 2018

1 reference

12 December 2020

Mesenchymal stem cells: characteristics and clinical applications.

1 reference

12 December 2020

Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11

1 reference

12 December 2020

Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by Human Liver Carboxylesterase

1 reference

12 December 2020

Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy

1 reference

12 December 2020

Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo

1 reference

12 December 2020

Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11).

1 reference

12 December 2020

TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways.

1 reference

12 December 2020

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

1 reference

12 December 2020

Identifiers

DOI

10.1038/CGT.2015.25

1 reference

7 September 2017

1 reference